Document is current
Any future updates will be listed below
-
Authors
Graham, Sophie https://orcid.org/0000-0002-7770-1863
Tessier, Elise
Stowe, Julia
Bernal, Jamie Lopez
Parker, Edward P. K. https://orcid.org/0000-0001-5847-109X
Nitsch, Dorothea https://orcid.org/0000-0001-5767-248X
Miller, Elizabeth
Andrews, Nick
Walker, Jemma L.
McDonald, Helen I.
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (NIHR200929)
- License Information
-
More Information
Article History
Received: 23 December 2022
Accepted: 21 June 2023
First Online: 6 July 2023
Competing interests
: The UK Health Security Agency (UKHSA) has provided vaccine manufacturers with post-marketing surveillance reports which the companies are required to submit to the UK Licensing Authority in compliance with their Risk Management Strategy, and a cost recovery charge is made for these reports. SG is also a part-time salaried employee of Evidera, which is a business unit of Pharmaceutical Product Development (PPD), part of Thermo Fisher Scientific. The remaining authors declare no competing interests.
